The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
QSAR Model for Drug Human Oral Bioavailability
Abstract
The quantitative structure-bioavailability relationship of 232 structurally diverse drugs was studied to evaluate the feasibility of constructing a predictive model for the human oral bioavailability of prospective new medicinal agents. The oral bioavailability determined in human adults was assigned one of four ratings and analyzed in relation to physicochemical and structural factors by the ORMUCS (ordered multicategorical classification method using the simplex technique) method. A systematic examination of various physicochemical parameters relating primarily to absorption, and structural elements which could influence metabolism, was carried out to analyze their effects on the bioavailabilty classification of drugs in the data set. Lipophilicity, expressed as the distribution coefficient at pH 6.5, was found to be a significant factor influencing bioavailability. The observation that acids generally had better bioavailability characteristics than bases, with neutral compounds between, led to the formulation of a new parameter, Delta log D (log D(6.5) - log D(7.4)), which proved to be an important contributor in improving the classification results. The addition of 15 structural descriptors relating primarily to well-known metabolic processes yielded a satisfactory QSAR equation which had a correct classification rate of 71% (97% within one class) and a Spearman rank correlation coefficient (R(s)) of 0.851, despite the diversity of structure and pharmacological activity in the compound set. In leave-one-out tests, an average of 67% of drugs were correctly classified (96% within one class) with an R(s) of 0.812. The relationship formulated identified significant factors influencing bioavailability and assigned them quantitative values expressing their contribution. The predictive power of the model was evaluated using a separate test set of 40 compounds, of which 60% (95% within one class) were correctly classified. Since the necessary physicochemical parameters can be calculated or estimated and the structural descriptors are obtained from an inspection of the structure, the model enables a rough estimate to be made of the prospective human oral bioavailability of unsynthesized compounds. Also, the model has the advantage of transparency in that it indicates which factors may affect bioavailabilty and the extent of that effect. This could be useful in designing compounds which are more bioavailable. Refinement of the model is possible as more bioavailability data becomes available. Potential uses are in drug design, prioritization of compounds for synthesis, and selection for detailed studies of early compound leads in drug discovery programs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QSAR: Hansch Analysis and Related Approaches
Kubinyi, H. (1993) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527616824 · Cited by 697
Simple Method of Calculating Octanol/Water Partition Coefficient.
MORIGUCHI, I., HIRONO, S., LIU, Q., NAKAGOME, I., & MATSUSHITA, Y. (1992) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.40.127 · Cited by 535
Use of distribution coefficients in quantitative structure-activity relations
Scherrer, R. A., & Howard, S. M. (1977) · Journal of Medicinal Chemistry · doi:10.1021/jm00211a010 · Cited by 235
Absorption Potential: Estimating the Fraction Absorbed for Orally Administered Compounds
Dressman, J. B., Amidon, G. L., & Fleisher, D. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740523 · Cited by 221
Zimm, S., Collins, J. M., O'Neill, D., Chabner, B. A., & Poplack, D. G. (1983) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1983.254 · Cited by 173
(B) Mechanisms of peptide and protein absorption
Burton, P. S., Conradi, R. A., & Hilgers, A. R. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90014-4 · Cited by 102
Absorption, Distribution, and Metabolism of Drugs
Austel, V., & Kutter, E. (1983) · Medicinal chemistry · doi:10.1016/b978-0-12-695150-9.50015-5 · Cited by 32
Tamorria, C. R., & Esse, R. C. (1965) · Journal of Medicinal Chemistry · doi:10.1021/jm00330a036 · Cited by 4
Cited by
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
Martin, Y. C. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0492002 · Cited by 1,020
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
Gleeson, M. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701122q · Cited by 969
Integration of virtual and high-throughput screening
Bajorath, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd941 · Cited by 930
Lipophilicity in drug discovery
Waring, M. J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003605098 · Cited by 873
The influence of lipophilicity in drug discovery and design
Arnott, J. A., & Planey, S. L. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.714363 · Cited by 868
A Novel Chemometric Method for the Prediction of Human Oral Bioavailability
Xu, X., Zhang, W., Huang, C., Li, Y., Yu, H., Wang, Y., Duan, J., & Ling, Y. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13066964 · Cited by 845
Urase, T., & Kikuta, T. (2005) · Water Research · doi:10.1016/j.watres.2005.01.015 · Cited by 397
Nonleadlikeness and leadlikeness in biochemical screening
Rishton, G. M. (2003) · Drug Discovery Today · doi:10.1016/s1359644602025722 · Cited by 381
Varma, M. V. S., Obach, R. S., Rotter, C., Miller, H. R., Chang, G., Steyn, S. J., El-Kattan, A., & Troutman, M. D. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901371v · Cited by 331
Waring, M. J. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.109 · Cited by 326
Role of Cyclodextrins in Improving Oral Drug Delivery
Loftsson, T., Brewster, M. E., & M??sson, M. (2004) · American Journal of Drug Delivery · doi:10.2165/00137696-200402040-00006 · Cited by 287
Quantitative structure-activity relationship methods: Perspectives on drug discovery and toxicology
Perkins, R., Fang, H., Tong, W., & Welsh, W. J. (2003) · Environmental Toxicology and Chemistry · doi:10.1897/01-171 · Cited by 286
Predicting ADME properties in silico: methods and models
Butina, D., Segall, M. D., & Frankcombe, K. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02288-2 · Cited by 284
Bennion, B. J., Be, N. A., McNerney, M. W., Lao, V., Carlson, E. M., Valdez, C. A., Malfatti, M. A., Enright, H. A., Nguyen, T. H., Lightstone, F. C., et al. (2017) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b02914 · Cited by 280
Progress in predicting human ADME parameters in silico
Ekins, S., Waller, C. L., Swaan, P. W., Cruciani, G., Wrighton, S. A., & Wikel, J. H. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00109-x · Cited by 274
Ursu, O., Rayan, A., Goldblum, A., & Oprea, T. I. (2011) · WIREs Computational Molecular Science · doi:10.1002/wcms.52 · Cited by 276
Physiologically-based pharmacokinetic simulation modelling
Grass, G. M., & Sinko, P. J. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00013-3 · Cited by 160
Applications of Human Pharmacokinetic Prediction in First-in-Human Dose Estimation
Zou, P., Yu, Y., Zheng, N., Yang, Y., Paholak, H. J., Yu, L. X., & Sun, D. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9332-y · Cited by 138
Metadata
- Authors
- Yoshida, F., & Topliss, J. G.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2000-06-01
- Volume
- 43
- Issue
- 13
- Pages
- 2575-2585
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1989451208
- Cited by
- 299
- References
- 8
- FWCI
- 22.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.